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Abstract: This ethnobotanical survey was carried out in Caspoggio (Valmalenco, SO, Italy) with
the purpose of investigating the traditional uses of medicinal plants. Moreover, a bibliographic
research meant to validate or refute the uses, focusing on the potentially responsible compounds,
was performed. Fifty-nine species, attributable to 30 families (Asteraceae, Pinaceae, Malvaceae, and
Lamiaceae the most cited), were mentioned. Arnica montana, anti-inflammatory for traumas and
musculoskeletal pains; Pinus mugo, expectorant; Malva sylvestris, anti-inflammatory and soothing;
Achillea moschata, digestive. The compounds, responsible for the therapeutic activities, are often
polyphenols and terpenoids: helenanin in A. montana, α-pinene, δ-3-carene, and limonene in P. mugo,
gossypin and malvin in M. sylvestris, luteolin and apigenin in A. moschata. Scientific evidence for
at least one of the traditional activities described was found for 50 species but only in 26 out of 196
works consulted, it is possible to make a comparison between investigated extracts and traditional
preparations. This study is thus a stimulus to new phytochemical investigations, mimicking as much
as possible the traditional preparations. This work is part of the European Interreg Italy-Switzerland
B-ICE project, aimed at creating a management model for the ongoing climate change and searching
for new sources of territory valorization as attractions for tourists.
Keywords: Valmalenco; ethnobotany; traditional uses; medicinal plants; climate change
1. Introduction
Ethnobotany of mountain regions is receiving increased interest in recent years [1] due to the
growing awareness about the impact of global warming on mountain biodiversity and the issues
of conservation and sustainable management of the landscape. Mountain areas are recognized to
be an important reservoir of ethnobotanical knowledge [2,3]. The high diversity of habitats and the
historical isolation of the local communities have led to a strong diversification of the local cultural
heritage. However, ethnobotanical knowledge is disappearing in mountain areas of many parts of
the world, particularly in developed countries, due to the ongoing socio-economic changes and the
loss of ethnic cultures. This process has been widely investigated, since loss of traditional knowledge
could result in declining capacities of local communities to manage and conserve their ecosystems [4]
and, therefore, has direct consequences on the use of biological resources by the next generations [5,6].
According to Dutfield [7] the erosion of ethnopharmacological knowledge and the abandonment of
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traditional practices might also involve a loss of access to a stock of bioactive compounds potentially
useful for therapeutic application and drug development. As pointed out in many papers [7,8],
traditional knowledge may be an important source of information in synthetic drug development
and in natural-product research. Several bioprospection studies aiming at investigating plant-based
biologically active agents have been developed in the recent years; the first step, and one of the major
challenges, is the selection of plants for pharmacological studies. According to an ethnodirected
approach, candidate plants can be selected by using information collected in ethnobotanical or
ethnopharmacological field researches and analyzed by using quantitative tools [9]. It should be noted
that traditional know-how is only a part of a large reservoir of available knowledge [7], including
database, books and journal papers; information reported by informants need to be verified and
validated through a comparison with the available scientific literature [7,8].
The present study is the first ethnobotanical investigation in Valmalenco (Figure 1). It is part of
the European Interreg Italy-Switzerland B-ICE project, aimed at creating a management model for the
ongoing climate change and searching for new opportunities of territory valorization as attractions for
tourists. Specifically, our work focused on Caspoggio, a village of about 1,400 inhabitants, located
at 1098 m above sea level, enclosed by the Bernina Alps. Situated at the border with Valtellina, in
the province of Sondrio (Lombardy–Italy), Valmalenco was an important link between Italy and
Switzerland due to a millenary thoroughfare that used to cross the entire valley: the ‘cavallera del
Muretto’ road. Between the 19th and 20th centuries, alternative passes were created and that ancient
road was closed, resulting in the impoverishment of the local society, economy, and territory.
Figure 1. Geographical position of Valmalenco (SO, Italy).
This study combines ethnobotanical field research with chemical and pharmacological information
reported in books and journal articles, in order to assess the pharmaceutical value of plants traditionally
used by people living in Valmalenco. Furthermore, through the rediscovering and valorization of
this traditional knowledge, the present study wants to provide basic information for an efficient and
sustainable approach to the use of the local natural resources.
In this research we: (1) investigated the traditional uses of plant species locally used for human
and animal healthcare; (2) consulted both ethnobotanical and pharmacological literature for scientific
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evidence meant to validate the traditional uses reported by the informants; (3) linked plants secondary
metabolites classes to the reported biological activities.
2. Results and Discussion
2.1. Field Work
A total of 137 informants were interviewed in Caspoggio. All collected data is summarized in Table
S1, providing for each cited species the family, the botanical name, the vernacular name, the used plant
part and preparation, the field of use, the category of use, and the detailed use. The last three columns
concern the bibliographic research carried out on the species and are thus organized: Bibliographic
reference: Ethnobotany (similar traditional uses throughout Italy and the world); Bibliographic
reference: Biological activity (in vitro, in vivo studies or clinical trials); Bibliographic reference: Active
compounds (studies on correlation between some of the active compounds of the species and their
potential biological activity described in Caspoggio).
The study provides information on 59 species (1659 citations) used for human and animal
healthcare, belonging to 53 genera and 30 botanical families. Asteraceae is the most cited family (692
citations for 13 species, 41.7% of the total citations), including plants both well known in the studied
area (e.g., Achillea moschata Wulfen, Arnica montana L., and Matricaria chamomilla L.) and multi-purpose
plants, e.g., used in different disease categories (e.g., Achillea millefolium L.). From the literature, it
is evident that Asteraceae is actually the most representative family in Valmalenco (with 46 species,
27.7% of the autochthonous species cited in a reference text concerning the spontaneous plants in the
province of Sondrio [10]). Other families with a high number of citations include either fewer species
(Pinaceae: 289 citations for four species; Malvaceae: 142 citations for two species) or many plants most
of which were less frequently cited by informants (Labiatae with 83 citations for Thymus spp. and
few citations for the others). Of the mentioned plants, 36 (61%) were herbaceous perennials, 15 (25%)
woody perennials and 3 sub-shrubs (5%). Annuals, biennials, lianas, ferns and lichens accounted for the
remaining 9%. 86.9% of citations concerning the use of wild species and only 6.6% of cultivated species
(Brassica oleracea L., Calendula officinalis L., Laurus nobilis L., Lavandula angustifolia Miller, Matricaria
chamomilla, Origanum vulgare L., Rosmarinus officinalis L., Salvia officinalis L., and Solanum tuberosum L.).
In 6.4% of the cases, the used species can be either wild or cultivated (Malva sylvestris L., Matricaria
chamomilla, Mentha x piperita L.). The main used parts are flowers (21 species; 642 citations) and leaves
(21 species; 301 citations) followed by the epigeous part (19; 222).
The most frequently reported method of preparation is infusion (736 citations; 44% of the total
citations), both for internal and external administration (oral use 71%, compress 18%, washing 5%,
footbath 1.5%, other 4.5%) followed by other preparation (e.g., the plant applied raw as poultice,
exudate etc.; 376 citations; 23% of the total citations), syrup (228; 14% of the total citations), and oleolite
(122; 7% of the total citations). Infusion from flowers or leaves is one of the most common methods
of preparation in phytomedical practice as it is very easy to prepare and allows the extraction of a
high quantity of bioactive metabolites. During our fieldwork, it was possible to acquire precious
information concerning other preparations of the traditional remedies, through direct observation of
the informants. As way of example, we mention the expectorant ‘syrup’, made through maceration
in sugar of green pinecones of P. mugo kept in glass jars under the sun for 60 days, or the dandelion
‘honey’, soothing in case of sore throat, obtained after boiling the inflorescences in water and lemon
juice, then covering them with sugar (Table 1). The dosage of the administered drugs and the duration
of the treatment are not fixed. Rarely, the informant gave us information about the potential toxicity of
some of the remedies if wrongly administered (i.e., the infusion of Achillea millefolium for stomachache
and menstrual pains, when prepared with more than three flowers or drunk for more than 3 days in
a row).
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Table 1. Some of the traditional preparations in the village of Caspoggio.
Species Preparation Traditional Recipe




Put the inflorescences in an empty glass flagon.
Keep it under the summer sun. Turn the flagon upside down
in order to help the exudate to leak from the inflorescences,
regularly gathering the liquid.
Calendula officinalis L. Calendula Macerated oil
Fill a glass jar to the brim with inflorescences. Cover the
flowers with almond oil. Keep the jar under the sun for
20–30 days. Filter the macerated oil.
Hypericum perforatum L.
Hypericum Macerated oil
Fill a glass jar to the brim with inflorescences collected in
June–July. Cover the flowers with almond, olive, or
sunflower oil. Keep the jar under the summer sun. Filter the
macerated oil in September.
Larix decidua Mill. Larch
Ointment
Mix 1 Kg of spruce and larch resin with 100g of butter, olive
oil, and bee wax until it reaches a smooth texture.Picea abies (L.) H.Karst Spruce
Pinus mugo Turra Mountain pine Pinecones syrup
Put green pinecones collected in June in a glass jar until they
reach the brim. Cover the pinecone completely with white
sugar. Keep the jar under the summer sun for 60 days,
shaking it at intervals. Filter the syrup.
Taraxacum spp. Dandelion Inflorescencessyrup
Put 100 flower heads in a glass jar and cover them with 100 g
of white sugar. Keep the jar under the summer sun for 30–40
days, until the sugar melts. Filter the syrup.
Most plants (44) are used individually while a few (15) are sometimes reported to be used in
mixtures (3% of the total citations). Some examples of mixtures are: an infusion of Achillea moschata
(epigeal part) and Matricaria chamomilla (flowers) to improve digestion; an infusion of Betula spp.
(leaves), Fraxinus excelsior (leaves), and Urtica dioica (leaves) as diuretic and depurative of the urinary
tract; an infusion of Juniperus communis (fruits), A. moschata (epigeal part), and Tilia spp. (flowers) as
digestive and as sedative; an unguent of Larix decidua (resin) and Pinus mugo (resin) as anti-inflammatory
and healing; an infusion of Laurus nobilis (leaves) and Salvia officinalis (leaves) as carminative; an
infusion of Pinus mugo (green cones) and Achillea moschata (epigeal part) as digestive; an alcoholic
macerate of Taraxacum spp. (flowers) and Gentiana lutea (roots) as digestive or a syrup of these plants
against the flu; an infusion of Thymus spp. (epigeal part) and Sambucus nigra (flowers) against cough.
The traditional use of the reported plants is considered ‘still relevant’ in 96.6% of citations,
‘uncertain’ in 2.9%, and ‘past’ in 0.2%. Though in most cases these remedies are persistent nowadays,
locals are aware of the declining number of individuals of some of the species. They report that the
presence of the cited plants in the past was ‘very frequent’ in 88.7% of the cases and ‘quite frequent’ in
11.1%, while nowadays is ‘very frequent’ in 60.3% and ‘quite frequent’ in 36.0%. As way of example,
the presence of Achillea moschata, Arnica montana, Artemisia genipi, and Gentiana lutea shifted from
‘very frequent’ in the past, to ‘quite frequent’ today. The last three have actually been in the list of
endangered species at least since 2013, year of publication of the updated Red List of Italian Flora
(Lista Rossa della Flora Italiana). Many a surveyed local people know about how harder and harder is
to find A. moschata and A. genipi today due to the retreat of perennial snow and glaciers, which forces
these two species to grow at higher altitudes, and to the indiscriminate collection by non-experts who,
tearing their roots, jeopardize the balance of their communities.
Medicinal uses include 1613 citations (97.2% of the total citations), pertaining to 55 species,
reported by 127 informants (93% of all the people interviewed). The most cited plants are Arnica
montana (99 informants; 294 citations), Achillea moschata (93; 124), Pinus mugo (89; 256), Malva sylvestris
(63; 108), Thymus spp. (52; 83), and Matricaria chamomilla (48; 98). All mentioned ailments are inserted
in 14 categories which, after making some adjustments to that of Economic Botany Data Collection
Standard (EBDCS) [11,12], fit best with the data acquired during the fieldwork (Table 2). Half of
the species (28) are used in only one (16) or two (12) categories; 19 of them are used in a number of
different categories ranging from three to five. The most versatile species are Salvia officinalis, Pinus
mugo, and Hypericum perforatum (six categories); Achillea millefolium (7), Achillea moschata (8), and Malva
sylvestris (12). As reported in Table S1 medicinal plants are mainly used to treat digestive tract disorders
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(28 species; 297 citations), respiratory tract infections (20; 348), general condition (20; 103), urinary tract
diseases (20; 73), and musculoskeletal system disorders and traumas (16; 410).
Table 2. Categories of use (pathologies treated in Caspoggio).
Category of Use (Pathologies) n. Species per Category n. Citations per Category ICF
Digestive tract disorders 28 297 0.91
Respiratory tract infections 20 348 0.95
General condition 20 103 0.81
Urinary tract disorders 20 73 0.74
Musculoskeletal system disorders and traumas 16 410 0.96
Skin diseases and traumas 14 140 0.91
Nervous system disorders 12 97 0.89
Circulatory system disorders 12 37 0.69
Gynecological disorders, obstetric and puerperal problems 8 21 0.65
Ophthalmic ailments 7 36 0.83
Other 7 19 0.67
Oropharyngeal cavity affections 6 25 0.79
Early infancy ailments 1 6 1.00
Afflictions of the ear 1 1
The Informant Consensus Factor (ICF) calculated for each disease category ranged from 0.65
to 1.00. As a rule, ICF values resulted to be high for uses reported by many informants, confirming
that people agree on plants to be used in the treatment of common diseases. The highest values
were recorded for early infancy ailments (ICF = 1.00), followed by musculoskeletal system diseases
(0.96), respiratory tract infections (0.94), digestive tract disorders, and skin diseases and traumas
(0.91); the lowest values for gynecological disorders, obstetric and puerperal problems (0.65). Some of
the highest agreement levels were recorded for ailments reported as the most widespread for alpine
communities ([3,13–15]). All these values were higher than those observed by Vitalini et al. [13] (ICF
ranging from 0.60 to 0.88) and Cornara et al. [14] (0.38–0.83) but very similar to those reported by Dei
Cas et al. [3] (0.80–0.92) and Vitalini et al. [15] (0.67–0.96). According to Heinrich et al. [16], informants’
consensus could be useful in selecting plants for pharmacological investigations. For this purpose, we
identified the species with the highest agreement among the informants (FI) in each of the categories
as a further helpful piece of information. For this analysis, we included the taxa cited at least five times
for a given use. The species with the highest agreement in the musculoskeletal systems diseases were
Brassica oleracea (FI = 100%; 19 citations), Arnica montana (92.9%; 92), Hypericum perforatum (85.7%; 24),
Achillea millefolium (40.5; 15), and Pinus mugo (26.9%; 24). For respiratory tract infections, the species
with the highest FI were Crataegus monogyna (100%; 5) and P. mugo (100%; 89), Sambucus nigra (91.7%;
11), and Thymus spp. (82.7%; 43). For digestive tract disorders: Achillea moschata (92.5%; 86), Gentiana
lutea (89.2; 33), and Artemisia genepi (84.6; 11). For skin diseases and traumas: Chelidonium majus (100%;
9), Calendula officinalis (80.9%; 17), Larix decidua (66.7%; 10), and Hypericum perforatum (46.4%; 13). Based
both on the FI values and the number of citations, other important uses in the local pharmacopoeia
were Matricaria chamomilla as sedative and hypnotic (97.9%; 47), against abdominal pain (41.6%; 20)
and as eyes anti-inflammatory (31.2%; 15), Vaccinium myrtillus to promote circulation (83.3%; 10) and to
promote eyesight/eyes health (75%; 9), Rosa canina as laxative and to promote digestion (75%; 9) and as
depurative (66.7%; 8), Malva sylvestris for treating stomachache and to promote digestion (52.4%; 33) as
generic anti-inflammatory (46%; 29), and for oropharyngeal affections (22.2%; 14), Plantago major for
treating skin traumas (50%; 10).
With respect to ethnobotanical studies, 11 works concerning the alpine and pre-alpine region
can be found in literature [2,3,13–15,17–22]. Only five of them were carried out in Lombardy, in
valleys surrounding Valmalenco: Valvestino (BS) [19], Val San Giacomo (SO) [13], Valfurva (SO) [3],
Tremezzina (CO) [17], and in the territory of Stelvio National Park (SO) [15]. These studies point out
that the most used species in folk medicine are Achillea moschata, Arnica montana, Thymus pulegioides,
and Artemisia genipi. A major part of the medicinal uses (71%) recorded in these studies are specific of
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a certain area; 54 of the uses cited by informants in Caspoggio have not been previously reported in
the consulted ethnobotanical literature of Italian Alpine areas and 53 of them are new for Italy (Table
S1). These findings highlight how mountain areas are important hotspots of biocultural diversity and
that different habitats as well as geographical factors and socio-cultural histories may deeply affect
human relationships with the natural resources. Jaccard’s similarity index shows values ranging from
7% (Valmalenco vs. Ligurian North Western Alps) to 27% (Valmalenco vs. Valfurva) with an average
value of 13% (Table 3). There is a significant negative correlation between geographic distance and
the Jaccard values (Spearman: −0.876; p < 0.05) suggesting that villagers inhabiting areas closer to
Valmalenco tend to have a similar knowledge of the use of medicinal plants. This is confirmed by a
dendrogram carried out on Jaccard’s similarity index showing that ethnopharmacological data from
Alpine areas of Lombardy cluster together while Piedmont and Liguria Alps group in a separated
cluster (Figure 2). Valvestino (VV) seems to be an exception showing the lowest similarity value (9%)
to our study area compared to the other Lombardy valleys; out of these areas, Valvestino is located at
the greatest distance from Valmalenco. Based on these results it may be assumed that communities
sharing ecological factors, historical backgrounds and sociocultural values have developed a similar
ethnobotanical knowledge; in addition, is also possible that an exchange of ethnobotanical knowledge
could have taken place, either recently or in the past, among the neighboring valleys.
Table 3. Comparison among ethnobotanical works in Alpine and Prealpine regions. Jaccard Similarity
Index of medicinal plant uses (veterinary excluded) in Valmalenco (VM) and in neighboring areas. VV:
Valvestino [19]; VSG: Val San Giacomo [13]; VF: Valfurva [3]; LS: Lombard Stelvio National Park [15];
WA1: Italian Western Alps [22]; WA2: Italian Western Alps [2]; NW: Italian North Western Alps [14];
VAR: Val Varaita [18]; TR: Tremezzina [17].









VM VV 19 162/66 0.09 [19] 162
VM VSG 41 140/133 0.18 [13] 140
VM VF 69 112/209 0.27 [3] 112
VM LS 89 92/539 0.16 [15] 92
VM WA1 17 164/53 0.08 [22] 164
VM WA2 22 159/130 0.08 [2] 159
VM NW 24 157/198 0.07 [14] 157
VM VAR 15 166/38 0.08 [18] 166
VM TR 48 133/181 0.18 [17] 133
Average 0.13 Average 142.78
Standard
deviation 26.11
Molecules 2020, 25, 4144 7 of 27
Figure 2. Cluster analysis of the medicinal plant use. Comparison among ethnobotanical works in
Alpine and Prealpine regions. Traditional uses in Valmalenco (VM) and in neighboring areas. VV:
Valvestino [19]; VSG: Val San Giacomo [13]; VF: Valfurva [3]; LS: Lombard Stelvio National Park [15];
WA1: Italian Western Alps [22]; WA2: Italian Western Alps [2]; NW: Italian North Western Alps [14];
VAR: Val Varaita [18]; TR: Tremezzina [17].
Veterinary uses include 46 citations (2.8 % of the total citations), pertaining to 15 species, reported
by 20 informants (1.5% of all the informants). The amount of knowledgeable informants is rather small
when compared to the 127 informants citing medicinal plants in the same community but comparable
to what reported in the other studies conducted in neighboring areas ([3,15]). We can hypothesize that
ethno-veterinary knowledge in the study area was once higher, but due to changing socioeconomic and
cultural values is currently disappearing, and only survives in the minds of a few informants. On the
other hand, the breeders prefer to vaccinate and to treat their animals with synthetic products rather
than rely on traditional herbal remedies. Four species (Carlina acaulis, Crocus vernus, Nepeta cataria, and
Rumex acetosa) have only a veterinary use while the other 11 have both animal and human medicinal
uses. Veterinary categories are based on the type of animals treated. The data acquired underline that
eight plant species are used in cattle, four in ‘other veterinary’ (that includes alpacas, cats, and dogs),
four are inserted in remedies for which the animal is not specified. Finally, one species is used in the
treatment of pigs. The most cited uses are Carduus nutans and Carlina acaulis flowers administered as
food for improving milk quality (eight citations, each), an infusion of Gentiana lutea roots to stimulate
digestion in cows (five citations) and an infusion of Matricaria chamomilla flowers as anti-inflammatory
for the eyes (five citations). It is important to point out that 13 of the cited veterinary uses have not
been previously reported for Italy (Supplementary Materials Table S1).
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2.2. Bibliographic Research
A bibliographic research was performed to find a possible match between the traditional uses
and the information reported in the scientific literature about the chemical composition and the
pharmaceutical activity of the cited species. A total of 196 scientific papers were identified. For 84.7% of
the reported species, we found scientific studies that could validate their medicinal use. However, for
some species (i.e., Vaccinium myrtillus and Valeriana officinalis) we found conflicting evidence. Species
with a higher number of citations, number of informants, and number of use categories in this research
have more often been subjected to scientific studies (Spearman’s Test: 0.456, p < 0.05; 0.443, p < 0.005;
0.481, p < 0.05). However, most of the medicinal species cited in Caspoggio have seldom been studied.
We present the comparison with scientific literature (for the complete data, please see Table
S1): Achillea millefolium digestive, anti-inflammatory for several problems (stomachache, muscular
pain, rash) and disinfectant [19,23–25]; Achillea moschata antioxidant and antibacterial [26]; Alchemilla
vulgaris anti-inflammatory [27,28]; Arnica montana anti-inflammatory for wounds, cutaneous traumas,
muscular, and articular pain [29–36]; Artemisia absinthium digestive [31,37–39] (however, in a
review from 2016 the potential antiulcer effect, with the decrease in the production of gastric
juice, is reported [40]); Artemisia genipi digestive and colds [39,41]; Betula pendula diuretic [42];
Calendula officinalis anti-inflammatory and disinfectant for wounds, rashes, and burns, improves
circulation [31,43–48]; Carduus nutans antimicrobial and anti-inflammatory [49]; Cetraria islandica
expectorant [50–52] and anti-inflammatory [51,53]; Chelidonium majus skin tags and warts [54,55];
Cichorium intybus depurative of the urinary tract [56,57]; Epilobium spp. anti-inflammatory [58,59],
depurative of the urinary tract [59]; Equisetum arvense diuretic [60–62], anti-inflammatory for
contusions [60,61,63–66], and analgesic [61,63,65]; Euphrasia officinalis eye inflammation [31,67,68];
Foeniculum vulgare anti-inflammatory, antispasmodic, and carminative [29,31,69,70]; Gentiana lutea
digestive [29,31,37,71]; Hipericum perforatum soothing and anti-inflammatory for skin rashes
and burns [23,31,72], muscular pain and contusions [72,73], and antidepressant [23,31,73–76];
Juniperus communis digestive [77–79]; Lamium album subsp. album diuretic [80,81]; Lavandula
angustifolia anti-inflammatory and disinfectant for wounds [29,82–85], sedative [29,31,86]; Larix decidua
anti-inflammatory and disinfectant for wounds and skin problems [31,87,88], antimicrobial [88]; Laurus
nobilis gastroprotective [89–91] and menstrual pains [92,93]; Linum usitatissimum improves intestinal
motility [94–96], expectorant, and decongestant [97]; Malva sylvestris gingivitis and inflammations of
the oral cavity [98–101], demulcent, skin anti-inflammatory and regenerative [100–105], depurative
of the urinary tract [106,107], and vaginal inflammation [101]; Matricaria chamomilla soothing
and ocular anti-inflammatory [31,67], antispasmodic for the gastrointestinal tract [31,43,108–110],
and sedative [31,43,108,109,111,112]; Melissa officinalis menstrual pains [113,114]; Mentha x piperita
anti-inflammatory [115–117]; Origanum vulgare anti-inflammatory [118–121]; Passiflora spp. sedative
hypnotic [122–126]; Plantago major anti-inflammatory and disinfectant for skin ailments [127–130],
cough [127,129,130], anti-inflammatory and infections [127–129]; Picea abies gingivitis and inflammation
of the oral cavity [88,131,132] and cough [31,88]; Pinus cembra cough and sore throat (antimicrobial) [133];
Pinus mugo anti-inflammatory [134], disinfectant [134], decongestant and expectorant [135,136];
Polypodium vulgare laxative [137]; Prunus avium diuretic [138]; Rosa canina diuretic and depurative
of the urinary tract [139], decongestant and anti-inflammatory for sore throat [139,140]; Rosmarinus
officinalis liver depurative [141–146]; Rumex alpinus disinfectant for wounds [147,148]; Salvia officinalis
gingivitis [149,150], gastrointestinal bloating [150], and anti-inflammatory [150–152]; Sambucus nigra
laxative [153], bronchitis, and other ailments of the upper airways [154–156]; Silybum marianum
hypolipidaemic, anti-atherosclerosis [157] and hepatoprotective [23,31,157,158]; Solanum tuberosum
anti-inflammatory [159–161]; Taraxacum spp. sore throat [162,163], skin inflammation [163], digestive
and prokinetic [163–165], kidney problems [163,165–167], and anti-inflammatory [163,165,168]; Thymus
spp. hypolipidaemic [144], balsamic and expectorant [169–172], and anti-inflammatory [170,171]; Urtica
dioica hypolipidaemic, anti-atherosclerosis, hepatoprotective, and diuretic [173,174], anti-inflammatory,
rheumatic pains, and contusions [65,173–176]; Vaccinium myrtillus maintenance of ocular health and
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function [146,177–184] (this last activity is refuted by a systematic review from 2004 [185]), improving of
blood circulation [146,178,183,186], and maintaining of urinary tract health [187]; Vaccinium vitis-idaea
maintaining of ocular health and function [180,181] and maintaining of urinary tract health [183,187,188];
Valeriana officinalis sedative hypnotic [189–195], though a systematic review from 2015 underlined no
significant variation between the valerian extract and the placebo [196].
No scientific evidence was found in literature concerning the activities emerged during the survey
and the following species: Brassica oleracea (articular pain and inflammation, decongestant for upper
airways), Carlina acaulis subsp. acaulis (galactagogue and throat depurative for cattles), Crocus vernus
(simil intoxicated state in cats after ingestion), Fraxinus excelsior (diuretic leaves infusion); Mentha
longifolia (tonic and corroborant), Oxalis acetosella (digestive); Nepeta cataria (given purposely by the
mother cat to her kittens); Rumex acetosa (improves milk and its taste if given to cows); Tilia spp.
(digestive, antitussive).
In accordance with the evidence, potential correlations among ethnobotanical uses of a
representative species, its phytochemistry, and its pharmacological properties are discussed hereafter,
with the purpose to carry out a preliminary assessment on the validation of traditional uses. The case
of Pinus mugo Turra was selected based not only on its importance in Valmalenco for frequency of
citations and peculiarity of its preparations, but also on the extent and relevance of information found
in scientific literature.
2.3. Pinus mugo Turra
Traditional uses in Valmalenco attribute to Pinus mugo activities on integumentary, digestive,
musculoskeletal, and respiratory systems, as well as veterinary purposes. Among the most cited
properties, we found anti-inflammatory and disinfectant, especially for skin traumas or the treatment
of cattle paws and hooves. Burns, frostbites, rushes, skin eruptions, and sprains are considered
pathological conditions treatable with this species, in addition to activities such as digestive, expectorant,
and decongestant, useful in the treatment of sore throat, cough, and colds. Different parts of the plant,
as well as different ways of administration are used with the purpose of reaching the desired effects.
Among the former are resin, sprouts, and cones. Among the latter, infusions, ointments, syrups, or the
direct application, especially for the resin. In this regard, a peculiar use is referred in case of bones
fractures: the fresh resin is melted, filtered, and applied directly on the fractured limb. Once hardened,
it makes a natural plaster cast, functional if kept for 30–40 days. The inhabitants of the valley believe
that the idle muscles are maintained strong and tonic by the resin, while a common plaster cast would
cause their weakening.
Other ethnobotanical surveys in neighboring valleys refer to the use of the infusion of P. mugo as
digestive, and of its syrup as expectorant [3,13,15,19]. From a pharmacological and phytochemical
point of view, there are few studies in literature that can support this use and they all are based on
characterization and evaluation of biological activity of the essential oil, often obtained from different
plant matrices and from different geographic origins [135,197,198].
In particular, one of the studies discusses three EO profiles, respectively obtained from needles,
twigs, and cones of P. mugo, as well as their anti-inflammatory and cytotoxic activities [134].
The anti-inflammatory activity was evaluated through the quantification of IL-6 cytokine secretion
by LPS-stimulated murine macrophages, while the cytotoxic effect was tested through a viability assay
of three different cancer cell lines after adding the EO.
In this study, the EOs from twigs and cones of P. mugo showed a significant anti-inflammatory
activity compared to the other two species of Pinus investigated, while the EOs from needles and
twigs asserted a strong cytotoxic activity on cancer cells. The former activity could be attributed to the
high concentration of α-pinene in the EOs. This molecule is actually considered responsible for the
inhibition of the secretion of several pro-inflammatory cytokines. Moreover, other major compounds,
such as limonene and δ-3-carene, could contribute to the down-regulation of neutrophil, resulting in a
reduction of the inflammatory response.
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Furthermore, hydrogen peroxide, found in the EO of adult individuals of P. mugo, could help
prolong the holding time of antimicrobial agents on the application site.
On the other hand, cytotoxic activity could be attribute to α-pinene, β-pinene, germacrene D, and
α-terpinol. Among these, α-pinene seems to be responsible for the antiproliferative activity on human
breast cancer cell line MCF-7 [134].
In light of the above, it is thus possible to justify the beneficial effects of P. mugo in several ailments
described in Valmalenco. Therefore, inflammatory conditions can be attributed to tissue and vascular
reactions caused by skin traumas, burns, rushes, skin eruptions, and sprains that can plausibly lead to
the production of inflammatory exudates, as well as heat, redness, and pain at an epithelium level.
The anti-inflammatory effect can be considered in case of skin wounds, applicable also in the
veterinary fields, where a purulent exudate can lead to a responsible infective agent.
The expectorant and decongestant properties, useful against sore throat, cough, and colds, can be
as well explained through the anti-inflammatory activity explicated on the upper airways mucosal
membranes. Some of the studies acknowledge to the EO of P. mugo antimicrobial action against
fungi, yeasts, gram-positive, and gram-negative bacteria [197], especially respiratory bacteria such as
Klebsiella, Morganella, Staphylococcus and Escherichia [135], as well as secretolytic effects [136], which can
improve the air flow through the airways.
All the EOs tested in these studies show δ-3-carene and α-pinene as major compounds to which,
synergistically with minor ones, the antimicrobial activity can be supposedly ascribed.
Therefore, these effects can be involved, together with the anti-inflammatory activity, in the
management of respiratory problems or skin wounds. Nevertheless, it is of utmost importance to
underline that the activities described in literature are attributed to the EO obtained from the species
while, in our case, the traditional preparations used are of a completely different nature.
Works such as ours gain value and importance in these observations, but they must be given
prompt response by phytochemical and pharmacological studies, with the purpose of investigating
traditional preparations and extracts and their potential biological activity.
No evidence was found concerning the digestive effects, nor the beneficial activity of the resin
compared to the common plaster cast.
The bibliographic research highlighted that data on the composition of secondary metabolites,
potentially related to biological activities, can be detected for 45 species out of 59. For some of these,
such as Achillea moschata, Artemisia absinthium, Linus usitatissimum, and Pinus mugo, there is extensive
data in respect of the different extractive methods and separation techniques, while for other species
the information is lacking.
It is necessary to underline that very few extracts studied in literature can be compared to the
traditional preparations cited in Caspoggio (only 26 out of the 196 studies consulted, related to 18
species. For more information, please see Table 4). For this reason, it is extremely hard to make
assumptions on the involvement of isolated compounds in the biological activity described.
Ultimately, for 14 species (Brassica oleracea, Carlina acaulis subsp. acaulis, Cichorium intybus,
Crataegus monogyna, Crocus vernus, Fraxinus excelsior, Lamium album, Melissa officinalis, Mentha longifolia,
Nepeta cataria, Oxalis acetosella, Prunus avium, Rumex acetosa and Tilia spp.) no information was found
about the correlation between their chemical characterization and the biological activity to which
the traditional uses can be ascribed. Some of these, such as B. oleracea (cataplasm for arthritis), C.
monogyna (upper airways infections), or M. officinalis (externally applied against menstrual pains), are
characterized by peculiar preparations and traditional uses that require more consideration.
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Table 4. Comparable extracts mentioned in literature with the traditional preparations.
Latin Name
Traditional Uses in Valmalenco
Type of Preparation in Literature Reference
Part of the Plant and Preparation Field of Use Category of Use Detailed Use
Achillea
millefolium L.





wound healing, Emollient, soothing
Hot water extract with hemostyptic
activity in vitro [25]
Aqueous extract with anti-inflammatory




tops (infusion) Med - Anti-oxidant
Aqueous extract with anti-oxidant




disorders Sedative hypnotic, promotes sleep







Kidney stones Cystitis and other
inflammation of the urinary tract
Urinary tract depurative Diuretic
Aqueous roots extract with diuretic
activity in rats [167]Leaves (infusion or decoction)














EtOH roots extract with choleretic









tops (macerated oil) Med
Skin diseases and
traumas
Sunburns, burns, frostbites, redness and
rash Anti-inflammatory, disinfectant and
wound healing Psoriasis Insect bites
Different types of macerated oils active
on burns and wounds [72]21 macerated oil samples of H.
(homemade or commercial) analyzed.
Pseudohypericin and hypericin in all
samples. Hyperforin in 4 samples.
Flowers/inflorescences/flowering




Contusions Sprains and dislocations
Articular pain and inflammations




(infusion/compresses with infusion) Med - Antioxidant activity




Epigeal part (Whole) (infusion) Med Digestive tract
disorders
Liver depurative
Choleretic and Hepatoprotective activity
of aqueous extracts in rats [141]
Hepatoprotective and antioxidant
activity of aqueous extract in rats [144]
Thymus spp.
Epigeal part (Whole) (infusion) Med Circulatory systemdisorders Blood depurative
Hepatoprotective and antioxidant





Balsamic Cough Colds and flu
symptoms Expectorant, decongestant,
emollient
Antimicrobial activity of aqueous extract [170,199]
Leaves (infusion)
Epigeal part (Whole) (infusion)
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Table 4. Cont.
Latin Name
Traditional Uses in Valmalenco
Type of Preparation in Literature Reference







Antiacid, gastritis, acid reflux
Carminative Abdominal pain





Seeds (boiled or left in water
overnight, then drunk) Med
Digestive tract
disorders Laxative, intestinal motility





with infusion) Med - Analgesic
Aqueous extract with analgesic activity
in rats (intraperitoneal administration) [100]
Leaves (infusion) Med Urinary tractdisorders Depurative
Nephroprotecive activity of aqueous
extract of leaves and flowers [106]
Epilobium spp. Leaves (infusion) Med General condition Anti-inflammatory
Aqueous extracts with activity on COX-1
and COX-2 [58]
Aqueous extracts with
anti-inflammatory activity in vitro [59]
Chelidonium
majus L. Latex or sap (applied raw) Med
Skin diseases and
traumas Skin tags and warts
Case report: 4-years child with warts





Epigeal part (Whole) (infusion) Med Respiratory tractinfections
Expectorant, decongestant,
emollientSorethroat and hoarseness
Anti-inflammatory activity of aqueous
extract in vitro [51]
Passiflora spp. Epigeal part (Whole) (infusion) Med Nervous systemdisorders Promotes sleep
Effect of infusion on Subjective sleep
quality [126]
Plantago major
L. Leaves (washing with infusion) Med
Oropharyngeal cavity
affections
Gingivitis, toothache, mouth ulcers and
abscesses
Anti-inflammatory activity of extract in
deionized water in vivo [129]
Rosa canina L. Fruits/infructescences/accessoryfruits (infusion) Med
Respiratory tract
infections Decongestant Sorethroat
Different aqueous extracts of rose hips
with anti-inflammatory activity [140]
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3. Materials and Methods
The research required the following steps:
• Preliminary Investigation on the Territory and the Local Flora
The present survey was carried out in the village of Caspoggio, in the territory of Valmalenco, a
tributary valley of the Valtellina, in the province of Sondrio (Lombardy, Italy). An early bibliographic
research concerning the typical local species was performed through the consultation of botany
textbooks focusing on the flora of the valleys of Sondrio [10]. Due to this preliminary investigation,
a table containing information on the autochthonous species (family, Latin name, common name,
and habitat) was produced [200]. We supported this list with a collection of images, which could be
consulted by the informants, with the purpose of helping species identification.
• Interview Management and Supporting Material
Opened and semi structured interviews were conducted through a questionnaire, consisting of
an “Informant Sheet” and a “Species Sheet”. In particular, the “Informant Sheet” was split into two
sections: the first one dedicated to the informant (personal data, location of the interview, education,
and job), the second one focused on the interview (duration, number of people present, level of
empathy, and any other useful notes).
The “Species Sheet” consisted of a 7-column table arranged as follows: Species (common and
vernacular name), Field of use, Detailed use, Preparation form, Administration form, Part of the plant,
Other information.
Each “Informant Sheet” was matched to a corresponding “Species Sheet”. Both were given the
same one-to-one alphanumeric identification code. The interviews were thus successively filed in
chronological order.
For each species, information was organized according to the Field of use (medicinal, veterinary,
etc.) and, eventually, in more detailed categories. For example, the medicinal field was divided into
several categories, one for every anatomical apparatus (Digestive tract disorders, Musculoskeletal
system disorders and traumas, etc.).
• Collection of Plant Material, Production of Herbarium Samples, and Photographic Archive
During the interviews and the excursions, plant material samples and traditional preparations
(liquors, syrups etc.) were collected and catalogued. Plant material was dried and used for
the production of herbarium samples that were archived as further support material for species
identification. With the same purpose, every step of the work was documented through photographs,
conveniently catalogued.
• Data Archiving and Analysis
All data obtained from the interviews were filed in a database, an Excel spreadsheet (Microsoft,
Redmond, WA, USA) where each row represents a citation, defined as a single use reported for a single
species by a single informant [201]. Each informant was archived with the one-to-one identification
code cited above.
Citations were considered as “distinct”, if differing from one another in at least one of the following
properties: species, informant, category of use, part of the plant, preparation, and administration
form. The standardization in the compilation of the database simplified both data browsing and
statistical elaboration.
Data tables were derived from this worksheet using the program “EBTools”, a collection of Visual
Basic for Applications (VBA) scripts executed within the Microsoft Excel framework. The scripts are
designed to perform advanced data sorting, filtering, and counting operations according to specific
user requirements.
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The Informant Consensus Factor (ICF) [202] indicates the agreement degree among the informants
(the closer the index is to 1, the higher is the agreement degree) concerning the use of species for the
treatment of ailments of different organ systems.
It was calculated as follows:
ICF = (nur − nt)/(nur − 1) (1)
where nur is the number of citations in each category; nt is the number of species used.
Informants’ consensus on medicinal uses was calculated for each species with the Fidelity Level
index (FL) reported by Friedman in 1986 [203]. It was calculated as follows:
Fl = Np/N × 100 (2)
where Np is the number of informants who reported the use of a species to treat a particular ailment,
and N is the total number of informants who mentioned the plant for any other disease.
We calculated Jaccard’s similarity index (JI) to compare data reported in our study with previously
published data collected from neighboring areas based on presence/absence of the reported uses. We
focused the analysis only on uses for human health because veterinary uses were not reported in all
the other considered studies. The following formula was applied:
JI = c/(a + b − c) × 100 (3)
where c is the number of species common to the two sites, a is the number of species used only in the
site A, and b is the number of species used only in the site B.
A cluster analysis was finally conducted on these data by using the PAST 3.32 software package
for Microsoft Windows.
Scientific Confirmation
Finally, an ethnobotanical, pharmacological, and phytochemical bibliographic research was carried
out about species used for human and animal healthcare, through search engines and online database
such as PubMed, MedLine, Google Scholar, and JANE.
Concerning the ethnobotanical research, the strategy was to combine the scientific or English
common name of the species and the keywords ‘ethnobotany’, ‘ethnopharmacology’, ‘traditional
medicine’, or ‘folk medicine’.
Regarding the pharmacology and phytochemistry, we paired the plant name with specific
keywords concerning the category of use cited in Valmalenco (i.e., Achillea moschata digestive system,
Pinus mugo respiratory system, Arnica montana musculoskeletal system) and then the specific pathology
or activity (i.e., Achillea moschata digestive, Pinus mugo cough, Arnica montana anti-inflammatory, Arnica
montana inflammation etc.).
We focused our attention particularly on systematic reviews and meta-analysis, when possible, or
on single in vitro, in vivo, and clinical trials studies, applying no time filters. Based on this data, specific
and detailed tables were produced (Table 4 and Supplementary Materials Table S1 [2,3,13–199,204–251]).
4. Conclusions
Documenting traditional medicinal uses can provide valuable information on locally available
species which can act as potential sources of new drugs or natural products. This is particularly
true in areas understudied from this perspective like the Alpine communities where our study has
been carried out. Alpine regions have an environmentally complex mosaic of different habitats as
well as historical and cultural peculiarities that have marked and shaped the development of a rich
ethnobotanical knowledge. Through a wide survey involving 137 informants, the present investigation
shows that traditional knowledge is still quite rich and alive in Valmalenco, and that medicinal plants
continue to play an important role for the local communities as part of their ancient cultural heritage.
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The high number of traditional uses (67) not previously documented for Italian Alpine areas provide
an evidence of this. Furthermore, the traditional use of medicinal plants cited is considered ‘still
relevant’ in 96.6% of citations, suggesting that medicinal uses are still practiced and transmitted within
the community.
Results of the pharmacological and phytochemical bibliographic research show that the scientific
information for the medicinal use of the plants cited in the ethnobotanical investigation is limited.
Specifically, little is found about the forms of preparation or quantities used; even when this information
is available the extracts analyzed are too often very different from the typical preparations of folk
medicine. Thus, it is difficult to confirm or validate traditional uses with laboratory experimentation.
Moreover, some of the species reported in the present work have never been investigated from this
perspective. A summary of these results is reported in Table S1 and we believe this could provide useful
information on what already exists from ethnobotanical and phytochemical studies. This represents an
encouragement to new investigations in this direction, meant to extend our current knowledge, with
the purpose of validating ancient traditional uses.
Lastly we are convinced that a tourism valorization of the local traditional knowledge can
be created and made tangible through innovative educational and leisure activities (for example,
through the establishment of a botanical garden where to cultivate and to show the medicinal plants
traditionally used by the local community; workshops introducing the identification of local medicinal
plants or the methods of preparing creams and ointments with the herbs; treasure hunts involving
children in the discovery of herbs, etc.). This approach can contribute to the safeguarding, promotion,
and development of an intangible cultural heritage and at the same time represents a valuable and
sustainable complement of the local touristic offering.
Supplementary Materials: The following are available online. Table S1. Bibliographic research on plants used for
human and animal healthcare.
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Mitrović, T.L.; Marin, P.D.; Zlatković, B.K.; Stojanović, G.S. Comparative study of the essential oils of four
Pinus species: Chemical composition, antimicrobial and insect larvicidal activity. Ind. Crops Prod. 2018, 111,
55–62. [CrossRef]
136. Ciuman, R.R. Phytotherapeutic and naturopathic adjuvant therapies in otorhinolaryngology. Eur. Arch. Oto
Rhino Laryngology 2012, 269, 389–397. [CrossRef]
137. European Medicines Agency Evaluation of Medicines for Human Use. EMEA Assessment Report on Polypodium
vulgare L., RHIZOMA; European Medicines Agency: London, UK, 2008.
138. Hooman, N.; Mojab, F.; Nickavar, B.; Pouryousefi-Kermani, P. Diuretic effect of powdered Cerasus avium
(cherry) tails on healthy volunteers. Pak. J. Pharm. Sci. 2009, 22, 381–383.
139. Selahvarzian, A.; Alizadeh, A.; Baharvand, P.A.; Eldahshan, O.A.; Rasoulian, B. Medicinal Properties of Rosa
canina L. Herb. Med. J. 2018, 3, 77–84. [CrossRef]
140. Winther, K.; Campbell-Tofte, J.; Vinther Hansen, A.S. Bioactive ingredients of rose hips (Rosa canina L.) with
special reference to antioxidative and anti-inflammatory properties: In vitro studies. Bot. Targets Ther. 2016,
6, 11–23. [CrossRef]
141. Al-Sereiti, M.R.; Abu-Amer, K.M.; Sen, P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its
therapeutic potentials. Indian J. Exp. Biol. 1999, 37, 124–130. [PubMed]
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187. Ştefănescu, B.E.; Szabo, K.; Mocan, A.; Crişan, G. Phenolic Compounds from Five Ericaceae Species Leaves
and Their Related Bioavailability and Health Benefits. Molecules 2019, 24, 2046. [CrossRef]
188. Davidson, E.; Zimmermann, B.F.; Jungfer, E.; Chrubasik-Hausmann, S. Prevention of Urinary Tract Infections
with Vaccinium Products. Phyther. Res. 2014, 28, 465–470. [CrossRef]
189. Abdellah, S.A.; Berlin, A.; Blondeau, C.; Guinobert, I.; Guilbot, A.; Beck, M.; Duforez, F. A combination of
Eschscholtzia californica Cham. and Valeriana officinalis L. extracts for adjustment insomnia: A prospective
observational study. J. Tradit. Complement. Med. 2020, 10, 116–123. [CrossRef]
190. Aliakbari, F.; Rafieian, M. The effectiveness of Valeriana officinalis on sleep disturbance in patients with chronic
heart failure. Int. J. Pharm. Investig. 2018, 8, 145–150. [CrossRef]
191. Bent, S.; Padula, A.; Moore, D.; Patterson, M.; Mehling, W. Valerian for Sleep: A Systematic Review and
Meta-Analysis. Am. J. Med. 2006, 119, 1005–1012. [CrossRef] [PubMed]
192. Mineo, L.; Concerto, C.; Patel, D.; Mayorga, T.; Paula, M.; Chusid, E.; Aguglia, E.; Battaglia, F. Valeriana
officinalis Root Extract Modulates Cortical Excitatory Circuits in Humans. Neuropsychobiology 2017, 75, 46–51.
[CrossRef] [PubMed]
193. Murphy, K.; Kubin, Z.J.; Shepherd, J.N.; Ettinger, R.H. Valeriana officinalis root
extractshavepotentanxiolyticeffectsin laboratoryrats. Phytomedicine 2010, 17, 674–678. [CrossRef]
[PubMed]
194. Murti, K.; Kaushik, M.; Sangwan, Y.; Kaushik, A. Pharmacological Properties of Valeriana officinalis—A
Review. Pharmacologyonline 2011, 3, 641–646.
195. Nandhini, S.; Narayanan, K.B.; Ilango, K. Valeriana officinalis: A Review of its Traditional Uses, Phytochemistry,
and Pharmacology. Asian J. Pharm. Clin. Res. 2018, 11, 36. [CrossRef]
196. Leach, M.J.; Page, A.T. Herbal medicine for insomnia: A systematic review and meta-analysis. Sleep Med.
Rev. 2015, 24, 1–12. [CrossRef]
197. Kurti, F.; Giorgi, A.; Beretta, G.; Mustafa, B.; Gelmini, F.; Testa, C.; Angioletti, S.; Giupponi, L.; Zilio, E.;
Pentimalli, D.; et al. Chemical composition, antioxidant and antimicrobial activities of essential oils of
different Pinus species from Kosovo. J. Essent. Oil Res. 2019, 31, 263–275. [CrossRef]
Molecules 2020, 25, 4144 25 of 27
198. Venditti, A.; Serrilli, A.M.; Vittori, S.; Papa, F.; Maggi, F.; Di Cecco, M.; Ciaschetti, G.; Bruno, M.; Rosselli, S.;
Bianco, A. Secondary metabolites from Pinus mugo Turra subsp. mugo growing in the Majella National Park
(Central Apennines, Italy). Chem. Biodivers. 2013, 10, 2091–2100. [CrossRef]
199. Aziz, M.A.; Adnan, M.; Khan, A.H.; Shahat, A.A.; Al-Said, M.S.; Ullah, R. Traditional uses of medicinal plants
practiced by the indigenous communities at Mohmand Agency, FATA, Pakistan. J. Ethnobiol. Ethnomed. 2018,
14, 2. [CrossRef]
200. Pignatti, S.; Guorino, R.; La Rosa, M. Flora d’Italia, 2nd ed.; Edagricole, Ed.; New Business Media: Bologna,
Italy, 2017.
201. Signorini, M.A.; Lombardini, C.; Bruschi, P.; Vivona, L. Conoscenze etnobotaniche e saperi tradizionali nel
territorio di San Miniato (Pisa). Atti. Soc. Tosc. Sci. Nat. Mem. Series B 2008, 1, 65–83.
202. Trotter, R.T.; Logan, M.H. Informant Consensus: A New Approach for Identifying Potentially Effective
Medicinalplants. In Plants in Indigenous Medicine & Diet: Biobehavioral Approaches; Etkin, N.L., Ed.; Redgrave
Publishing Company: Bedford Hills/New York, NY, USA, 1986; pp. 91–112.
203. Friedman, J.; Zohara, Y.; Amotz, D.; Palewitch, D. A preliminary classification of the healing potential of
medicinal plants, based on a rational analysis of an ethnopharmacological field survey among Bedouins in
the Negev Desert, Israel. J. Ethnopharmacol. 1986, 16, 275–278. [CrossRef]
204. Mustafa, B.; Hajdari, A.; Pieroni, A.; Pulaj, B.; Koro, X.; Quave, C.L. A cross-cultural comparison of folk plant
uses among Albanians, Bosniaks, Gorani and Turks living in south Kosovo. J. Ethnobiol. Ethnomed. 2015, 11.
[CrossRef]
205. Guarrera, P.M. Traditional phytotherapy in Central Italy (Marche, Abruzzo, and Latium). Fitoterapia 2005, 76,
1–25. [CrossRef] [PubMed]
206. Lucchetti, L.; Zitti, S.; Taffetani, F. Ethnobotanical uses in the Ancona district (Marche region, Central Italy). J.
Ethnobiol. Ethnomed. 2019, 15, 9. [CrossRef] [PubMed]
207. Silva, P.T.M.; Silva, M.A.F.; Silva, L.; Seca, A.M.L. Ethnobotanical knowledge in sete cidades, azores
archipelago: First ethnomedicinal report. Plants 2019, 8, 256. [CrossRef] [PubMed]
208. Grabherr, G. Biodiversity in the high ranges of the Alps: Ethnobotanical and climate change perspectives.
Glob. Environ. Chang. 2009, 19, 167–172. [CrossRef]
209. Abbet, C.; Mayor, R.; Roguet, D.; Spichiger, R.; Hamburger, M.; Potterat, O. Ethnobotanical survey on
wild alpine food plants in Lower and Central Valais (Switzerland). J. Ethnopharmacol. 2014, 151, 624–634.
[CrossRef] [PubMed]
210. Aro, A.A.; Perez, M.O.; Vieira, C.P.; Esquisatto, M.A.M.; Rodrigues, R.A.F.; Gomes, L.; Pimentel, E.R. Effect of
Calendula officinalis cream on achilles tendon healing. Anat. Rec. 2015, 298, 428–435. [CrossRef]
211. Grosu, E.; Ichim, M.C. Turning Meadow Weeds Into Valuable Species for the Romanian Ethnomedicine While
Complying with the Environmentally Friendly Farming Requirements of the European Union’s Common
Agricultural Policy. Front. Pharmacol. 2020, 11, 1–12. [CrossRef]
212. Zheleva-Dimitrova, D.; Zhelev, I.; Dimitrova-Dyulgerova, I. Antioxidant Activity of Some Carduus Species
Growing in Bulgaria. Free Radic. Antioxid. 2011, 1, 15–20. [CrossRef]
213. Street, R.A.; Sidana, J.; Prinsloo, G. Cichorium intybus: Traditional Uses, Phytochemistry, Pharmacology, and
Toxicology. Evid. Based Complement. Altern. Med. eCAM 2013, 2013, 579319. [CrossRef] [PubMed]
214. Satmbekova, D.; Srivedavyasasri, R.; Orazbekov, Y.; Omarova, R.; Datkhayev, U.; Ross, S.A. Chemical and
biological studies on Cichorium intybus L. Nat. Prod. Res. 2018, 32, 1343–1347. [CrossRef] [PubMed]
215. Subiza, J.L.; Subiza, J.L.; Alonso, M.; Hinojosa, M.; Garcia, R.; Jerez, M.; Subiza, E. Allergic conjunctivitis to
chamomile tea. Ann. Allergy 1990, 65, 127–132. [PubMed]
216. Srivastava, J.K.; Gupta, S. Extraction, characterization, stability and biological activity of flavonoids isolated
from chamomile flowers. Mol. Cell. Pharmacol. 2009, 1, 138–147. [CrossRef]
217. Shin, S.; Lee, J.-A.; Kim, M.; Kum, H.; Jung, E.; Park, D. Anti-Glycation Activities of Phenolic Constituents
from Silybum marianum (Milk Thistle) Flower in Vitro and on Human Explants. Molecules 2015, 20, 3549–3564.
[CrossRef]
218. Kashiwada, Y.; Takanaka, K.; Tsukada, H.; Miwa, Y.; Taga, T.; Tanaka, S.; Ikeshiro, Y. Sesquiterpene Glucosides
From Anti-Leukotriene B4 Release Fraction of Taraxacum officinale. J. Asian Nat. Prod. Res. 2001, 3, 191–197.
[CrossRef]
219. Sahu, N.; Arya, K. Ethnobotanical and ethnopharmacological activites of Artemisia nilagirica, Lyonia ovalifolia,
Sarcococca saligna and Taraxacum officinale. J. Chem. Inf. Model. 2017, 8, 4818–4825. [CrossRef]
Molecules 2020, 25, 4144 26 of 27
220. Park, C.M.; Park, J.Y.; Noh, K.H.; Shin, J.H.; Song, Y.S. Taraxacum officinale Weber extracts inhibit LPS-induced
oxidative stress and nitric oxide prodction via the NF-κB modulation in RAW 264,7 cells. J. Ethnopharmacol.
2011, 133, 834–842. [CrossRef]
221. Azman, N.A.M.; Skowyra, M.; Muhammad, K.; Gallego, M.G.; Almajano, M.P. Evaluation of the antioxidant
activity of Betula pendula leaves extract and its effects on model foods. Pharm. Biol. 2017, 55, 912–919.
[CrossRef]
222. Pavlovic, M.; Kovacevic, N.; Tzakou, O.; Couladis, M. The essential oil of Valeriana officinalis L. s.l. growing
wild in western serbia. J. Essent. Oil Res. 2004, 16, 397–399. [CrossRef]
223. Fernandez, A.; Edwin Cock, I. The Therapeutic Properties of Juniperus communis L.: Antioxidant Capacity,
Bacterial growth Inhibition, Anticancer Activity and Toxicity. Pharmacogn. J. 2016, 8, 273–280. [CrossRef]
224. Al-Snafi, A.E. Medical Importance of Juniperus communis—A Review. Indo Am. J. Pharm. Sci. 2018, 5,
1779–1792. [CrossRef]
225. Cioanca, O.; Hancianu, M.; Mihasan, M.; Hritcu, L. Anti-acetylcholinesterase and Antioxidant Activities of
Inhaled Juniper Oil on Amyloid Beta (1–42)-Induced Oxidative Stress in the Rat Hippocampus. Neurochem.
Res. 2015, 40, 952–960. [CrossRef] [PubMed]
226. Raudone, L.; Vilkickyte, G.; Pitkauskaite, L.; Raudonis, R.; Vainoriene, R.; Motiekaityte, V. Antioxidant
Activities of Vaccinium vitis-idaea L. Leaves within Cultivars and Their Phenolic Compounds. Molecules 2019,
24, 844. [CrossRef] [PubMed]
227. Mirzaee, F.; Hosseini, A.; Jouybari, H.B.; Davoodi, A.; Azadbakht, M. Medicinal, biological and phytochemical
properties of Gentiana species. J. Tradit. Complement. Med. 2017, 7, 400–408. [CrossRef] [PubMed]
228. Rostami, H.; Kazemi, M.; Shafiei, S. Antibacterial activity of Lavandula officinalis and Melissa officinalis against
some human pathogenic bacteria. Asian J. Biochem. 2012, 7, 133–142. [CrossRef]
229. Mori, H.-M.; Kawanami, H.; Kawahata, H.; Aoki, M. Wound healing potential of lavender oil by acceleration
of granulation and wound contraction through induction of TGF-β in a rat model. BMC Complement. Altern.
Med. 2016, 16, 144. [CrossRef]
230. Miraj, S.; Rafieian-Kopaei, M.; Kiani, S. Melissa officinalis L: A Review Study With an Antioxidant Prospective.
J. Evid. Based. Complementary Altern. Med. 2017, 22, 385–394. [CrossRef]
231. Ahmad, M.; Sultana, S.; Fazl-i-Hadi, S.; ben Hadda, T.; Rashid, S.; Zafar, M.; Khan, M.; Khan, M.P.; Yaseen, G.
An Ethnobotanical study of Medicinal Plants in high mountainous region of Chail valley (District Swat
Pakistan). J. Ethnobiol. Ethnomed. 2014, 10, 36. [CrossRef]
232. Teweldemedhin, M.; Gebreyesus, H.; Atsbaha, A.H.; Asgedom, S.W.; Saravanan, M. Bacterial profile of
ocular infections: A systematic review. BMC Ophthalmol. 2017, 17, 1–9. [CrossRef]
233. Kerkoub, N.; Panda, S.K.; Yang, M.-R.; Lu, J.-G.; Jiang, Z.-H.; Nasri, H.; Luyten, W. Bioassay-Guided Isolation
of Anti-Candida Biofilm Compounds From Methanol Extracts of the Aerial Parts of Salvia officinalis (Annaba,
Algeria). Front. Pharmacol. 2018, 9, 1418. [CrossRef] [PubMed]
234. Sakkas, H.; Papadopoulou, C. Antimicrobial Activity of Basil, Oregano, and Thyme Essential Oils. J. Microbiol.
Biotechnol. 2017, 27, 429–438. [CrossRef] [PubMed]
235. Dall’Acqua, S.; Viola, G.; Giorgetti, M.; Loi, M.C.; Innocenti, G. Two new sesquiterpene lactones from the
leaves of Laurus nobilis. Chem. Pharm. Bull. 2006, 54, 1187–1189. [CrossRef] [PubMed]
236. Caputo, L.; Nazzaro, F.; Souza, L.; Aliberti, L.; De Martino, L.; Fratianni, F.; Coppola, R.; De Feo, V. Laurus
nobilis: Composition of Essential Oil and Its Biological Activities. Molecules 2017, 22, 930. [CrossRef]
[PubMed]
237. Jeambey, Z.; Johns, T.; Talhouk, S.; Batal, M. Perceived health and medicinal properties of six species of wild
edible plants in north-east Lebanon. Public Health Nutr. 2009, 12, 1902–1911. [CrossRef]
238. Neha, S.; Ritu, R.; Manju, K.; Birendra, K. A review on biological activities of hydrazone derivatives. Int. J.
Pharm. Clin. Res. 2016, 8, 162–166.
239. Ouelbani, R.; Bensari, S.; Mouas, T.N.; Khelifi, D. Ethnobotanical investigations on plants used in folk
medicine in the regions of Constantine and Mila (North-East of Algeria). J. Ethnopharmacol. 2016, 194,
196–218. [CrossRef]
240. Pranskuniene, Z.; Ratkeviciute, K.; Simaitiene, Z.; Pranskunas, A.; Bernatoniene, J. Ethnobotanical Study of
Cultivated Plants in Kaišiadorys District, Lithuania: Possible Trends for New Herbal Based Medicines. Evid.
Based Complement. Altern. Med. 2019, 2019. [CrossRef]
Molecules 2020, 25, 4144 27 of 27
241. Tsioutsiou, E.E.; Giordani, P.; Hanlidou, E.; Biagi, M.; De Feo, V.; Cornara, L. Ethnobotanical Study of
Medicinal Plants Used in Central Macedonia, Greece. Evid. Based Complement. Altern. Med. 2019, 2019.
[CrossRef]
242. Vogl, S.; Picker, P.; Mihaly-Bison, J.; Fakhrudin, N.; Atanasov, A.G.; Heiss, E.H.; Wawrosch, C.; Reznicek, G.;
Dirsch, V.M.; Saukel, J.; et al. Ethnopharmacological in vitro studies on Austria’s folk medicine—An
unexplored lore in vitro anti-inflammatory activities of 71 Austrian traditional herbal drugs. J. Ethnopharmacol.
2013, 149, 750–771. [CrossRef]
243. Yang, G.; Lee, K.; Lee, M.-H.H.; Kim, S.-H.H.; Ham, I.-H.H.; Choi, H.-Y.Y. Inhibitory effects of Chelidonium
majus extract on atopic dermatitis-like skin lesions in NC/Nga mice. J. Ethnopharmacol. 2011, 138, 398–403.
[CrossRef] [PubMed]
244. Baldan, V.; Sut, S.; Faggian, M.; Dalla Gassa, E.; Ferrari, S.; De Nadai, G.; Francescato, S.; Baratto, G.;
Dall’Acqua, S. Larix decidua Bark as a Source of Phytoconstituents: An LC-MS Study. Molecules 2017, 22, 1974.
[CrossRef] [PubMed]
245. Dar, P.A.; Sofi, G.; Jafri, M.A. Polypodium vulgare Linn. a versatile herbal medicine: A review. Int. J. Pharm.
Sci. Res. 2012, 3, 1616–1620. [CrossRef]
246. Naz, S.B.; Chaudhry, M.A.; Rahaman, S.U. Dual receptors blocked mechanism arbitrates smooth muscles
relaxant effect of Polypodium vulgare. Bangladesh J. Pharmacol. 2016, 11, 414. [CrossRef]
247. Khan, A.; Siddiqui, A.; Jafri, M.A.; Asif, M. Ethnopharmacological Studies of Polypodium vulgare Linn: A
Comprehensive Review. J. Drug Deliv. Ther. 2018, 8, 73–76. [CrossRef]
248. Ghedira, K.; Goetz, P.; Le Jeune, R. Alchemilla vulgaris L.: Alchémille (Rosaceae). Phytothérapie 2012, 10,
263–266. [CrossRef]
249. Caliskan, O. Mediterranean Hawthorn Fruit (Crataegus) Species and Potential Usage. In The Mediterranean
Diet: An Evidence-Based Approach; Elsevier: Amsterdam, The Netherlands, 2015; pp. 621–628.
250. Djeddi, S.; Boutaleb, H. Evaluation of antioxidative and antibacterial potentials of Crataegus monogyna Jacq.
from Evaluation of antioxidative and antibacterial potentials of Crataegus monogyna Jacq. from Mahouna
mountain ( Algeria ). J. Adv. Sci. Appl. Eng. 2015, 1, 60–63.
251. Malanga, G.A.; Yan, N.; Stark, J. Mechanisms and efficacy of heat and cold therapies for musculoskeletal
injury. Postgrad. Med. 2015, 127, 57–65. [CrossRef]
Sample Availability: Samples of the compounds are not available from the authors.
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
